Skip to main content
Log in

C-peptide blood levels in keto-acidosis and in hyperosmolar non-ketotic diabetic coma

  • Original Contributions
  • Published:
Acta diabetologia latina Aims and scope Submit manuscript

Summary

For further evaluation of B-cell secretion in diabetic keto-acidosis (KA) and in non-ketotic hyperosmolar coma (NKHC), basal and post-i.v. tolbutamide blood CPR and IRI values were measured in 34 patients (22 KA and 12 NKHC). FFA, cortisol and HGH measurements were also performed. IRI was low in both KA and NKHC (0.07±0.01 and 0.082±0.01 nmol/l) as opposed to CPR which was significantly higher in NKHC (1.14±0.1 nmol/l) than in KA (0.21±0.03 nmol/l). After tolbutamide injection, CPR and IRI levels did not change in any of the KA cases, whereas they significantly increased in half of the NKHC cases. Cortisol and FFA values were similarly increased in both situations, as opposed to HGH which was significantly higher (6.1±1.2 ng/ml) in KA than in NKHC (1.9±0.2 ng/ml). These results suggest that B-cell function is less deficient in NKHC than in KA. Residual insulin amounts reaching the liver via the portal vein could partly account for the absence of ketosis in NKHC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alberti K. G. M. M., Johnston D. G., Gill A., Barnes A. J., Ørskov H.: Hormonal regulation of ketone body metabolism in man - Biochem. Soc. Symp.43, 163, 1978.

    PubMed  Google Scholar 

  2. Barnes A. J., Kohner E. M., Bloom S. R., Johnston D. G., Alberti K. G. M. M., Smythe P.: Importance of pituitary hormones in aetiology of diabetic ketoacidosis - Lancet1, 1171, 1978.

    PubMed  Google Scholar 

  3. Chupin M., Charbonnel B., Dubin B., Remi J. P., Guillon J.: Profil hormonal et métabolique du coma hyperosmolaire diabétique. Réponse insulinique au tolbutamide intra-veineux - Diab. Metab.4, 243, 1978.

    Google Scholar 

  4. Duncombe W. G.: The colorimetric microdetermination of NEFA in plasma - Clin. chim. Acta9, 122, 1964.

    Google Scholar 

  5. Gerich J. E., Martin M. M., Recant L.: Clinical and metabolic characteristics of hyperosmolar non ketotic coma - Diabetes20, 228, 1971.

    PubMed  Google Scholar 

  6. Girard J., Pegorier J. P.: Régulation de la cétogénèse hépatique - In: Journées Annuelles de Diabétologie de l'Hôtel-Dieu, Paris 1979. Flammarion Éd., Paris, 1979; p. 233.

    Google Scholar 

  7. Hockaday T. D. R., Alberti K. G. M. M.: Diabetic coma - Clin. Endocr. Metab.1, 751, 1972.

    Google Scholar 

  8. Horwitz D. L., Starr J. I., Mako M. E., Blackard W. G., Rubinstein A. H.: Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood - J. clin. Invest.55, 1278, 1975.

    PubMed  Google Scholar 

  9. Joffe B. I., Krut L. H., Goldberg R. B., Seftel H. C.: Pathogenesis of non ketotic hyperosmolar diabetic coma - Lancet1, 1069, 1975.

    PubMed  Google Scholar 

  10. Johnson R. D., Conn J. W., Calvin M. D., Dyckman J., Pek S., Starr J. I.: Mechanisms and management of hyperosmolar coma without ketoacidosis in the diabetic - Diabetes18, 111, 1969.

    PubMed  Google Scholar 

  11. Kaneko T., Oka H., Munemura M., Yamashita K., Suzuki S., Yanaihara N., Hashimoto T., Yanaihara C.: Radioimmunoassay of human proinsulin C-peptide using synthetic human connecting peptide - Endocr. jap.21, 141, 1974.

    Google Scholar 

  12. Katz A. I., Rubinstein A. H.: Metabolism of proinsulin, and C-peptide in the rat - J. clin. Invest.52, 1113, 1973.

    PubMed  Google Scholar 

  13. Kühl C., Faber O. K., Hornnes P., Lindkaer Jensen S.: C-peptide metabolism and the liver - Diabetes27 (Suppl. 1), 197, 1978.

    PubMed  Google Scholar 

  14. Lindsey C. A., Faloona G. R., Unger R. H.: Plasma glucagon in non ketotic hyperosmolar coma - J. Amer. med. Ass.229, 1771, 1974.

    Google Scholar 

  15. Mc Garry J. D.: New perspectives in the regulation of ketogenesis - Diabetes28, 517, 1979.

    PubMed  Google Scholar 

  16. Malvano R., Zuchelli G. C.: Insulin radioimmunoassay: a comparison of three methods - J. nucl. Biol. Med.18, 80, 1974.

    PubMed  Google Scholar 

  17. Metcalfe P., Alberti K. G. M. M., Hinks L., Johnston D. G., Randall P. G., Turnell D., Ørskov H.: Ketogenic effect of growth hormone in normal man - Diabetologia15, 255, 1978; abstract # 234.

    Google Scholar 

  18. Müller W. A., Faloona G. R., Unger R. H.: Hyperglucagonemia in diabetic keto-acidosis: its prevalence and significance - Amer. J. Med.54, 52, 1973.

    PubMed  Google Scholar 

  19. Regeur L., Binder C.: The correlation between plasma C-peptide and kidney function - Diabetologia12, 416, 1976; abstract #223.

    Google Scholar 

  20. Ruder H. J., Guy R. L., Lipsett M. B.: Radioimmunoassay for cortisol in plasma and urine - J. clin. Endocr.35, 219, 1972.

    PubMed  Google Scholar 

  21. Unger R. H.: Role of glucagon in the pathogenesis of diabetes: the status of the controversy - Metabolism27, 1691, 1978.

    PubMed  Google Scholar 

  22. Vinik A., Seftel H. C., Joffe B. I.: Metabolic findings in hyperosmolar non ketotic diabetic stupor - Lancet2, 797, 1970.

    PubMed  Google Scholar 

  23. Yalow R. S., Glick S. M., Roth J., Berson S. A.: Plasma insulin and growth hormone levels in obesity and diabetes - Ann. N.Y. Acad. Sci.131, 357, 1965.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chupin, M., Charbonnel, B. & Chupin, F. C-peptide blood levels in keto-acidosis and in hyperosmolar non-ketotic diabetic coma. Acta diabet. lat 18, 123–128 (1981). https://doi.org/10.1007/BF02098997

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02098997

Key-words

Navigation